PFM Health Sciences, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
PFM Health Sciences, LP disclosed 67 US equity positions worth $1.2bn in its Q3 2025 13F filing. The largest position was LLY at 14.6% of the reported book, followed by THC and AXSM. Against the Q2 2025 filing, it opened 14 new positions, added to 13 and reduced 21 among the top 50 holdings.
What did PFM Health Sciences, LP own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 14.6% | $171.8m | 225,139 | -16% | reduced |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 8.0% | $93.7m | 461,654 | -8% | reduced |
| 3 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 5.5% | $64.4m | 530,332 | 10% | added |
| 4 | MCK MCKESSON CORP | Healthcare | 4.8% | $55.9m | 72,313 | 0% | held |
| 5 | PEN PENUMBRA INC | Healthcare | 4.2% | $49.4m | 195,085 | 17% | added |
| 6 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.4% | $40.1m | 95,650 | 163% | added |
| 7 | ISRG INTUITIVE SURGICAL INC | Healthcare | 3.0% | $34.6m | 77,403 | -13% | reduced |
| 8 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 2.5% | $29.7m | 381,324 | -3% | reduced |
| 9 | ASND ASCENDIS PHARMA A/S | Healthcare | 2.5% | $28.9m | 145,311 | -34% | reduced |
| 10 | HCA HCA HEALTHCARE INC | Healthcare | 2.4% | $28.0m | 65,773 | -9% | reduced |
| 11 | CVS CVS HEALTH CORP | Healthcare | 2.2% | $26.1m | 346,679 | -28% | reduced |
| 12 | COR CENCORA INC | Healthcare | 2.1% | $25.2m | 80,493 | 51% | added |
| 13 | OM OUTSET MED INC | 2.1% | $24.4m | 1,729,921 | 4% | added | |
| 14 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 2.0% | $23.8m | 116,260 | – | new |
| 15 | ICLR ICON PLC | Healthcare | 2.0% | $23.4m | 133,683 | 52% | added |
| 16 | CNC CENTENE CORP DEL | Healthcare | 1.7% | $20.5m | 574,360 | – | new |
| 17 | MRK MERCK & CO INC | Healthcare | 1.7% | $19.8m | 236,468 | – | new |
| 18 | ELV ELEVANCE HEALTH INC FORMERLY | Healthcare | 1.7% | $19.6m | 60,776 | – | new |
| 19 | NTRA NATERA INC | Healthcare | 1.6% | $18.6m | 115,596 | 14% | added |
| 20 | ADMA ADMA BIOLOGICS INC | Healthcare | 1.5% | $17.3m | 1,181,011 | – | new |
| 21 | NEO NEOGENOMICS INC | Healthcare | 1.5% | $17.0m | 2,208,530 | 187% | added |
| 22 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.4% | $17.0m | 327,174 | -37% | reduced |
| 23 | SLNOEUR SOLENO THERAPEUTICS INC | 1.4% | $16.5m | 243,401 | -40% | reduced | |
| 24 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.4% | $16.2m | 666,196 | 93% | added | |
| 25 | ASND ASCENDIS PHARMA A/S | 1.3% | $15.7m | 11,515,000 | -50% | reduced | |
| 26 | OSCR OSCAR HEALTH INC | Healthcare | 1.3% | $15.5m | 820,642 | 12% | added |
| 27 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.3% | $15.5m | 331,069 | – | new |
| 28 | VERA VERA THERAPEUTICS INC | Healthcare | 1.3% | $14.9m | 513,685 | – | new |
| 29 | SPY SPDR S&P 500 ETF TR | 1.2% | $14.1m | 21,210 | 24% | added | |
| 30 | INDIVIOR PLC | 1.2% | $13.5m | 561,526 | -59% | reduced | |
| 31 | VEEV VEEVA SYS INC | Healthcare | 1.1% | $12.4m | 41,503 | – | new |
| 32 | MERUS N V | 1.0% | $12.3m | 130,742 | -29% | reduced | |
| 33 | AKERO THERAPEUTICS INC | 1.0% | $11.8m | 248,079 | -7% | reduced | |
| 34 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.0% | $11.2m | 19,890 | – | new |
| 35 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 1.0% | $11.2m | 64,998 | -26% | reduced |
| 36 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.8% | $9.5m | 1,662,836 | -7% | reduced |
| 37 | WAT WATERS CORP | Healthcare | 0.8% | $9.2m | 30,751 | -29% | reduced |
| 38 | VRNA VERONA PHARMA PLC | 0.7% | $8.6m | 80,416 | 0% | held | |
| 39 | INBX INHIBRX BIOSCIENCES INC | 0.7% | $8.1m | 239,644 | -2% | reduced | |
| 40 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 0.7% | $8.0m | 57,246 | 347% | added |
| 41 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.6% | $7.2m | 356,818 | -71% | reduced |
| 42 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 0.6% | $6.8m | 360,460 | -61% | reduced |
| 43 | CGON CG ONCOLOGY INC | Healthcare | 0.5% | $6.4m | 157,874 | – | new |
| 44 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.5% | $5.9m | 436,156 | -40% | reduced |
| 45 | COO COOPER COS INC | Healthcare | 0.4% | $5.1m | 74,363 | – | new |
| 46 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.4% | $4.9m | 48,162 | – | new |
| 47 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.4% | $4.8m | 183,538 | 386% | added |
| 48 | WST WEST PHARMACEUTICAL SVSC INC | Healthcare | 0.4% | $4.8m | 18,365 | – | new |
| 49 | AZN ASTRAZENECA PLC | Healthcare | 0.4% | $4.7m | 61,795 | – | new |
| 50 | ARGX ARGENX SE | Healthcare | 0.4% | $4.7m | 6,403 | -12% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.